GB9524131D0 - Pyrido-pyrimidine compounds as tyrosine kinase inhibitors - Google Patents

Pyrido-pyrimidine compounds as tyrosine kinase inhibitors

Info

Publication number
GB9524131D0
GB9524131D0 GBGB9524131.1A GB9524131A GB9524131D0 GB 9524131 D0 GB9524131 D0 GB 9524131D0 GB 9524131 A GB9524131 A GB 9524131A GB 9524131 D0 GB9524131 D0 GB 9524131D0
Authority
GB
United Kingdom
Prior art keywords
pyrido
tyrosine kinase
kinase inhibitors
pyrimidine compounds
pyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9524131.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Pharmacia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia SpA filed Critical Pharmacia SpA
Priority to GBGB9524131.1A priority Critical patent/GB9524131D0/en
Publication of GB9524131D0 publication Critical patent/GB9524131D0/en
Priority to CA002209598A priority patent/CA2209598C/en
Priority to BR9607089A priority patent/BR9607089A/en
Priority to HU9801177A priority patent/HUP9801177A3/en
Priority to AT96934673T priority patent/ATE201873T1/en
Priority to US08/860,717 priority patent/US5965563A/en
Priority to PCT/EP1996/004460 priority patent/WO1997018212A1/en
Priority to JP9518527A priority patent/JPH10512896A/en
Priority to ES96934673T priority patent/ES2159760T3/en
Priority to AU72920/96A priority patent/AU7292096A/en
Priority to PL96321296A priority patent/PL321296A1/en
Priority to EP96934673A priority patent/EP0802914B1/en
Priority to EA199700107A priority patent/EA000072B1/en
Priority to DE69613211T priority patent/DE69613211T2/en
Priority to IL12109096A priority patent/IL121090A0/en
Priority to CN96191448A priority patent/CN1168138A/en
Priority to ARP960105153A priority patent/AR004320A1/en
Priority to MXPA/A/1997/005010A priority patent/MXPA97005010A/en
Priority to NO973198A priority patent/NO973198D0/en
Pending legal-status Critical Current

Links

GBGB9524131.1A 1995-11-14 1995-11-24 Pyrido-pyrimidine compounds as tyrosine kinase inhibitors Pending GB9524131D0 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
GBGB9524131.1A GB9524131D0 (en) 1995-11-24 1995-11-24 Pyrido-pyrimidine compounds as tyrosine kinase inhibitors
CN96191448A CN1168138A (en) 1995-11-14 1996-10-14 Aryl and Heteroaryl Purine Compounds
ES96934673T ES2159760T3 (en) 1995-11-14 1996-10-14 DERIVATIVES OF ARIL PURINA AND PIRIDOPIRIMIDINA AND HETEROARIL PURINA AND PIRIDOPIRIMIDINA.
PL96321296A PL321296A1 (en) 1995-11-14 1996-10-14 Derivatives of aryl and heteroaryl purine
HU9801177A HUP9801177A3 (en) 1995-11-14 1996-10-14 Tetrahydronaphthyl, indanyl and indolyl substituted pyrido[2,3-d]pyrimidine and purine derivatives, process for their preparation and pharmaceutical compositions containing them
AT96934673T ATE201873T1 (en) 1995-11-14 1996-10-14 ARYL AND HETEROARYL PURINE AND PYRIDOPYRIMIDINE DERIVATIVES
US08/860,717 US5965563A (en) 1995-11-14 1996-10-14 Aryl and heteroaryl purine compounds
PCT/EP1996/004460 WO1997018212A1 (en) 1995-11-14 1996-10-14 Aryl and heteroaryl purine compounds
JP9518527A JPH10512896A (en) 1995-11-14 1996-10-14 Aryl and heteroaryl purine compounds
CA002209598A CA2209598C (en) 1995-11-14 1996-10-14 Aryl and heteroaryl purine compounds
AU72920/96A AU7292096A (en) 1995-11-14 1996-10-14 Aryl and heteroaryl purine compounds
BR9607089A BR9607089A (en) 1995-11-14 1996-10-14 Bicyclic condensed pyrimidine compounds pharmaceutical composition use and products containing them and process for the preparation of these compounds
EP96934673A EP0802914B1 (en) 1995-11-14 1996-10-14 Aryl- and heteroaryl- purine and pyridopyrimidine derivatives
EA199700107A EA000072B1 (en) 1995-11-14 1996-10-14 Aryl and heteroaryl purine compounds
DE69613211T DE69613211T2 (en) 1995-11-14 1996-10-14 ARYL AND HETEROARYL PURINE AND PYRIDOPYRIMIDINE DERIVATIVES
IL12109096A IL121090A0 (en) 1995-11-14 1996-10-14 Aryl and heteroaryl purine compounds
ARP960105153A AR004320A1 (en) 1995-11-14 1996-11-13 NEW BICYCLE CONDENSED PIRIMIDINE COMPOUNDS; A PROCEDURE FOR ITS PREPARATION; PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS THERAPEUTIC AGENTS, IN PARTICULAR AS INHIBITORS OF THE TYROSINE KINASE.
MXPA/A/1997/005010A MXPA97005010A (en) 1995-11-14 1997-07-02 Aril- and heteroaril-pur compounds
NO973198A NO973198D0 (en) 1995-11-14 1997-07-09 Aryl and heteroaryl purine compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9524131.1A GB9524131D0 (en) 1995-11-24 1995-11-24 Pyrido-pyrimidine compounds as tyrosine kinase inhibitors

Publications (1)

Publication Number Publication Date
GB9524131D0 true GB9524131D0 (en) 1996-01-24

Family

ID=10784444

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9524131.1A Pending GB9524131D0 (en) 1995-11-14 1995-11-24 Pyrido-pyrimidine compounds as tyrosine kinase inhibitors

Country Status (1)

Country Link
GB (1) GB9524131D0 (en)

Similar Documents

Publication Publication Date Title
GB9604361D0 (en) 4-Substituted pyrrolopyrimidine compounds as tyrosine kinase inhibitors
GB9501567D0 (en) Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors
IL127796A0 (en) Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
GB9507298D0 (en) Substituted indolylmethylene-oxindale analogues as tyrosine kinase inhibitors
AU7289696A (en) Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
AU3693697A (en) Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
EG24381A (en) Tyrosine kinase inhibitors
AP2000001861A0 (en) Bicylic heteroaromatic compounds as protein tyrosine kinase inhibitors
HUS1700048I1 (en) Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
GB2346877B (en) 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
AU7631496A (en) Substituted 2-anilinopyrimidines useful as protein kinase inhibitors
AU6411698A (en) Substituted 2-anilinopyrimidines useful as protein kinase inhibitors
AU3766897A (en) Fused heterocyclic compounds as protein tyrosine kinase inhibitors
NZ323571A (en) Protein kinase c inhibitor
PL346934A1 (en) Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
AU4956297A (en) Raf kinase inhibitors
PL340727A1 (en) Benzothiazolic inhibitors of proteinous thyrosinic kinase
PL336990A1 (en) 3(5)-heteroaryl group substituted pyrazoles as inhibitors of kinase p 38
AU2396897A (en) 5-aminopyrazoles useful as selective inhibitors of the protein tyrosine kinase p56ick
IL123124A0 (en) Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors
AU1518595A (en) Antagonists to insulin receptor tyrosine kinase inhibitor
GB9611797D0 (en) Substituted quinolylmethylen-oxindole analogues as tyrosine kinase inhibitors
GB9610964D0 (en) Substituted tetralylmethylen-oxindole analogues as tyrosine kinase inhibitors
GB9524131D0 (en) Pyrido-pyrimidine compounds as tyrosine kinase inhibitors
GB9600997D0 (en) N-indolinyl-pyridopyrimidines as tyrosine kinase inhibitors